CEO SUMMARY: In a surprise move that further consolidates national anatomic pathology services, NeoGenomics will acquire Clarient Inc., from General Electric Healthcare. General Electric is getting cash, and preferred and common stock. The two companies announced plans to pursue integrated diagnostic services that would combine lab testing and diagnostic imaging data. The deal is subject […]
NeoGenomics to Acquire Clarient for $275 Million
Annual revenue at NeoGenomics will more than double once this transaction is closed
- By Joseph Burns
- > From the Volume XXII No. 15 - October 26, 2015 Issue
- Tags: Anatomic pathology, anatomic pathology services, clinical trials, diagnostic testing, Diagnostic tests, digital pathology, genomics, ihc test, impac, informatics, integrated diagnostic, integrated diagnostics, lab test, lab testing, lab testing services, managed care, managed care organization, managed care organizations, molecular assay, molecular assays, molecular diagnostic, molecular diagnostic test, molecular diagnostic testing, molecular diagnostic testing companies, Pathology group, pathology groups, pathology service, pathology services, pathology test, pathology testing, testing laboratory
